J THORAC ONCOL 润色咨询

Journal of Thoracic Oncology

出版年份:2006 年文章数:186 投稿命中率:26.25%

出版周期:Monthly 自引率:6.1% 审稿周期:平均1.5月

前往期刊查询

投稿信息

投稿信息
审稿速度
平均1.5月 (网友贡献,非官方数据)
投稿命中率
26.25% (网友贡献,非官方数据)
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2019年中国人文章占该期刊总数量16.31% (2018年为21.38%)
自引率
6.1 %
年文章数
186
期刊官网
点击查看 (点击次数:12149)
点击查看 (点击次数:3212次)
作者需知
点击查看 (点击次数:259次)
期刊简介
稿件收录要求
Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. JTO emphasizes a multidisciplinary approach and includes original research reviews and opinion pieces. The audience includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology. The journal is interested in receiving manuscripts dealing with epidemiology, prevention, screening, early detection, staging, cure, and treatment of thoracic malignancies. Submissions on tobacco control and cessation are of interest, particularly where there is direct relevance to lung cancer epidemiology and therapeutic outcomes. The Journal also welcomes submissions on pathologic and histologic classification and novel imaging and bronchoscopic approaches. Submissions regarding novel systemic therapies, particularly in the fields of biomarker targets, genomics, immunology, and cellular therapies are of interest. Novel radiotherapy and surgical techniques are of interest. Submission of randomized phase II and phase III trials, as well as meta analyses of individual participant data, are encouraged. Basic science studies must have direct clinical and translational relevance.